AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity (Q43211411)
Jump to navigation
Jump to search
scientific article published on 22 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity |
scientific article published on 22 December 2009 |
Statements
1 reference
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity (English)
1 reference
1 reference
1 reference
Christine M Chresta
1 reference
Barry R Davies
1 reference
Tom Harding
1 reference
Sabina Cosulich
1 reference
Susan E Critchlow
1 reference
John P Vincent
1 reference
Darren Jones
1 reference
Patrizia Sini
1 reference
Dominic James
1 reference
Zoe Howard
1 reference
Phillippa Dudley
1 reference
Gareth Hughes
1 reference
Lisa Smith
1 reference
Sharon Maguire
1 reference
Marc Hummersone
1 reference
Karine Malagu
1 reference
Keith Menear
1 reference
Richard Jenkins
1 reference
Matt Jacobsen
1 reference
Graeme C M Smith
1 reference
Sylvie Guichard
1 reference
Martin Pass
1 reference
22 December 2009
1 reference
1 reference
70
1 reference
1
1 reference
288-298
1 reference
Identifiers
1 reference
1 reference